Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-17

Clinical Trial Update: Quercetin as Possible Supportive Therapy for Mild to Moderate Hyperuricemia [NA]

View source ↗

Summary

A completed clinical trial evaluated quercetin as a potential supportive therapy for mild to moderate hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quercetin (quercetin)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Hyperuricemia | NA | Status: COMPLETED